NCT02653560View on ClinicalTrials.gov

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Hypertension
Interventions
DRUG

Potassium chloride powder

DRUG

Potassium magnesium Citrate (KMgCit)

DRUG

Potassium citrate powder

DRUG

Placebo

Trial Locations (1)

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02653560 - Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension | Biotech Hunter | Biotech Hunter